Tango Therapeutics rebounds with a stronger pipeline, renewed focus on PRMT5 inhibitors, and key data ahead despite past ...

Autolus Therapeutics plc delivers a breakthrough CAR-T therapy for B-ALL with strong safety/efficacy. Learn more about AUTL ...

Vera Therapeutics stock rocketed nearly 70% on Monday on upbeat data for a kidney-disease trial. Shares are tumbling Friday ...

The HT2 trait in canola is designed to offer a more effective solution for controlling weeds resistant to commonly used herbicides. With the agricultural industry facing challenges from such resistant ...

Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...

Vesting of each stock option is subject to such employee's continued service to Taysha on each vesting date. Taysha Gene Therapies (Nasdaq: TSHA) is a clinical-stage biotechnology company focused on ...

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

The Puerto Rico Science, Technology and Research Trust and the National Institute for Innovation in Manufacturing ...

Burning Rock Biotech Limited (NASDAQ: BNR, the "Company" or "Burning Rock"), a company focused on the application of next generation sequencing (NGS) ...

For decades, things went well for Bellevue Group. But now the sector weakness in biotechs could lead to losses.

Total gross proceeds of up to $150.0 million before the end of 2026 if all Series B warrants and Series C warrants are ...

Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...